Trial NCT00324324

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000472877
Secondary IDs: OHSU 0285 OHSU-TPI-02027-L P30CA069533

Last trial update was posted on 2017-05-09

MeSH Interventions

Moxifloxacin Norgestimate, ethinyl estradiol drug combination

MeSH Conditions

Bacterial Infections Breast Neoplasms Communicable Diseases Infections Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myelodysplastic-Myeloproliferative Diseases Myeloproliferative Disorders Neoplasms Neoplasms, Germ Cell and Embryonal Neoplasms, Plasma Cell Neuroblastoma Plasmacytoma Preleukemia Syndrome Trophoblastic Neoplasms

Other Conditions

Breast Cancer Chronic Myeloproliferative Disorders Gestational Trophoblastic Tumor Infection Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic/Myeloproliferative Neoplasms Ovarian Cancer Testicular Germ Cell Tumor

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID